IUVO Therapeutics

Active Risk: not assessed

Private limited companyfounded 2026active for less than a yearKoloniënstraat 11, 1000 Brussel, Belgium305 active companies are registered at this addressKBO/BCE: BE 1035.117.682

From the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette

Summary

IUVO Therapeutics is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The 2026 annual accounts show equity of €2.6m. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

IUVO TherapeuticsActive

Risk analysis Report Compare

Official details

KBO

Status: Active since 04-03-2026 Normal situation
Legal form: Private limited company
Registered office: Koloniënstraat 11, 1000 Brussel
Activity: “L’investissement, la souscription, la prise ferme, le placement, la vente, l’achat et la négociation…” (deed in French)From the articles, 11 activitiesNo NACE code in the KBO yet
Establishment unit: 2.395.583.264 1000 Brussel, since 04-03-2026
Financial year end: 4 March
Peppol: Reachable

Company details

Who decides

Board

LUBOSCH-HAENISCH Jonathan Wolfgang BernhardDirector
ORIANI Andrea UmbertoDirector
SCHNARR Christopher JamesDirector

Board & ownership

How it is doing

Too few figures to scoreToo young for a bankruptcy probability

Annual accounts to 04-03-2026

Equity: €2.6m
Total assets: €5.0m

2026 accounts 186 days early

Filed on 01-04-2026PDF

Financials

Signalsraises riskYoung companyneutralLatest accounts filed on timeShow the evidence

Checked score

No current score

Insufficient figures

A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.

Bankruptcy probability, 12 months

This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Two signals.

raises riskneutral

Young company

Founded in 2026, less than a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.

KBO · incorporation date

Age against the risk zone

Latest accounts filed on time

The financial year that closed on 04-03-2026 was due by 04-10-2026 and was filed on 01-04-2026, 186 days ahead of the deadline.

NBB · 1 filing

Deviation from the deadline

2026

186 days early

← before the deadline after the deadline →

Searched, nothing found (1)

No strike-offs in the KBO publications

Searched since incorporation in 2026.

KBO publications · our coverage

Documents

Key facts about IUVO Therapeutics

What is the company number of IUVO Therapeutics?: 1035.117.682. In Belgium the VAT number is the company number with BE in front: BE 1035.117.682.
Where is IUVO Therapeutics based?: The registered office is at Koloniënstraat 11, 1000 Brussel.Company details
What is the legal form of IUVO Therapeutics?: Private limited company (BV).
When was IUVO Therapeutics founded?: On 04-03-2026.
Is IUVO Therapeutics still active?: Yes, IUVO Therapeutics is an active enterprise in the KBO register.
What is the turnover of IUVO Therapeutics?: The annual accounts for financial year 2026 state no turnover.Financials
Where can I find the annual accounts of IUVO Therapeutics?: IUVO Therapeutics filed 1 annual account with the National Bank of Belgium, for financial year 2026.Annual accounts 2026 (PDF)